Purchase 500 million yuan worth of financial products from REMEGEN (09995).
Rongchang Biotechnology (09995) announced that on October 15, 2025, the company entered into an agreement with the Yantai Branch of Shanghai Pudong Development Bank...
REMEGEN (09995) announced that on October 15, 2025, the company entered into a Wealth Management Product Agreement with the Shanghai Pudong Development Bank Yantai Branch. According to this agreement, the company agreed to (1) use 400 million RMB of idle own funds to purchase wealth management products from the Shanghai Pudong Development Bank Yantai Branch, and (2) use 100 million RMB of idle raised funds to purchase wealth management products from the Shanghai Pudong Development Bank Yantai Branch.
Related Articles

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


